What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
McDermott + Bull Partner Ken Dropiewski sits down with Lightstone Ventures General Partner Mike Carusi to explore essential topics for CEOs and investors. Mike provides an inside look at Lightstone Ventures’ focus areas and shares his perspective on current...
McDermott + Bull has successfully placed Lisa Henry as Vice President, Clinical and Regulatory at Magenta Medical. Reporting to the CEO, Lisa will lead the clinical and regulatory strategies critical to Magenta’s success. As the first U.S.-based team member, Lisa will...
McDermott + Bull has successfully placed Hussain Rangwala as Chief Technology Officer at Inari Medical. Reporting to the CEO, Hussain will drive the development and execution of innovative R&D strategies, including fostering a culture of innovation, ensuring...
McDermott + Bull has successfully placed Helen Routh and Beverly Huss as members of the Board of Directors at Clarius Mobile Health. They will bring their vast expertise in healthcare technology and medical devices to help Clarius continue to innovate and grow. Their...
McDermott + Bull Partner Ken Dropiewski sits down with Catalyst Health Ventures Managing Partner Darshana Zaveri to discuss several key topics relevant to CEOs and investors alike. Darshana shares insights on how CEOs can best prepare for a productive meeting with...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
